LOINCActiveBoth

LOINC Code 73822-9: Chr X and Y aneuploidy Dosage of chromosome-specific cfDNA Nom (cfDNA)

73822-9 is a LOINC code used to identify Chr X and Y aneuploidy Dosage of chromosome-specific cfDNA Nom (cfDNA) in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Fetal chromosome X & Y aneuploidy. It is commonly used with the system or sample type Plas.cfDNA.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Fetal chromosome X & Y aneuploidy. It is commonly used with the system or sample type Plas.cfDNA.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both
  • Method: Dosage of chromosome specific cf DNA

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

  • Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Nominal
  • Fetal chromosome X & Y aneuploidy
  • Sex chromosome (X & Y) analysis to determine gender (XY or XX) or presence of aneuploidy can be determined based on dosage of chromosome specific ccf DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal aneuploidy as well as trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age. The submitter's lab reports results as male fetus, female fetus, or aneuploidy. For aneuploidy cases, the results of the specific findings (e.g. YY, XYY, XXX, etc.) are reported as well.
  • Chr X + Y aneup; Chromosom; Chromosomes; Finding; Findings; Molecular pathology; MOLPATH; Nominal; Pl; Plasma; Plsm; Point in time; Random; Spec

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Chr X and Y aneuploidy Dosage of chromosome-specific cfDNA Nom (cfDNA)Chromosome X and Y aneuploidy in Plasma cell-free DNA by Dosage of chromosome-specific cfDNA NominalChr X + Y aneup Plas.cfDNAFetal chromosome X & Y aneuploidyMOLPATHFetal Chromosome X and Y AneuploidyFind

Frequently asked questions

Code details

Code73822-9
SystemLOINC
Display nameChr X and Y aneuploidy Dosage of chromosome-specific cfDNA Nom (cfDNA)
DescriptionFetal chromosome X & Y aneuploidy
Short nameChr X + Y aneup Plas.cfDNA
ComponentFetal chromosome X & Y aneuploidy
PropertyFind
TimingPt
System (specimen)Plas.cfDNA
ScaleNom
MethodDosage of chromosome specific cf DNA
ClassMOLPATH
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.44
Last changed2.73

Consumer names

Fetal Chromosome X and Y Aneuploidy

Part names

Fetal chromosome X & Y aneuploidyFindPtPlas.cfDNANomDosage of chromosome specific cf DNAFetal chromosome X and Y aneuploidyFindingPoint in time (spot)Plasma cell-free DNADosage of chromosome-specific cfDNA

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.

LOINC Code 73822-9 | HealthAssure